pMSCV-IRES-mAmetrine 1.1 FP Citations (3)

Originally described in: Vignali lab plasmids
Unpublished

---

Articles Citing pMSCV-IRES-mAmetrine 1.1 FP

Articles
Retinoic acid and TGF-beta orchestrate organ-specific programs of tissue residency. Obers A, Poch T, Rodrigues G, Christo SN, Gandolfo LC, Fonseca R, Zaid A, Kuai JEY, Lai H, Zareie P, Yakou MH, Dryburgh L, Burn TN, Dosser J, Buquicchio FA, Lareau CA, Walsh C, Judd L, Theodorou MR, Gutbrod K, Dormann P, Kingham J, Stinear T, Kallies A, Schroeder J, Mueller SN, Park SL, Speed TP, Satpathy AT, Phan TG, Wilhelm C, Zaph C, Evrard M, Mackay LK. Immunity. 2024 Nov 12;57(11):2615-2633.e10. doi: 10.1016/j.immuni.2024.09.015. Epub 2024 Oct 14. PubMed
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. Yuan S, Sun R, Shi H, Chapman NM, Hu H, Guy C, Rankin S, Kc A, Palacios G, Meng X, Sun X, Zhou P, Yang X, Gottschalk S, Chi H. Nature. 2025 Apr;640(8060):1062-1071. doi: 10.1038/s41586-025-08732-6. Epub 2025 Mar 19. PubMed
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte function. Scharping NE, Ge X, Matias MI, Jiang F, Cafferata A, Heeg M, Monell A, Galletti G, Cheung KP, Rock A, Thao N, Shuttleworth SL, Bauer MA, Takehara KK, Ferry A, Quon S, Koss B, Myers SA, Bennett EJ, Goldrath AW. Cell. 2026 May 14;189(10):2857-2874.e31. doi: 10.1016/j.cell.2026.02.019. Epub 2026 Apr 29. PubMed

If you have published an article using this material, please email us at to have your article added to this page.